Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$8.51 -0.9%	$7.25	$6.00 ▼ $12.95	$134.09M	1.29	72,968 shs	31,169 shs
DGX Quest Diagnostics	$178.85 +1.3%	$176.31	$136.99 ▼ $182.38	$19.71B	0.49	991,754 shs	436,517 shs
HIMS Hims & Hers Health	$47.92 +1.0%	$51.83	$13.47 ▼ $72.98	$10.62B	2.02	23.39 million shs	17.39 million shs
LFMD LifeMD	$12.55 -3.0%	$11.21	$3.99 ▼ $15.84	$587.64M	2.4	1.08 million shs	902,588 shs
LH Labcorp	$261.89 +0.7%	$251.44	$198.96 ▼ $265.72	$21.76B	0.82	640,698 shs	271,298 shs
LLY Eli Lilly and Company	$779.60 +0.0%	$775.72	$677.09 ▼ $972.53	$738.55B	0.4	3.66 million shs	1.45 million shs
MED Medifast	$14.58 -0.3%	$13.42	$11.57 ▼ $22.66	$160.69M	0.86	240,742 shs	104,789 shs
NVO Novo Nordisk A/S	$69.05 -1.1%	$69.82	$57.00 ▼ $143.69	$311.75B	0.64	7.25 million shs	4.05 million shs
TDOC Teladoc Health	$8.24 -1.4%	$7.31	$6.35 ▼ $15.21	$1.46B	1.84	6.37 million shs	3.88 million shs
WW WW International	$0.25 -10.5%	$0.33	$0.12 ▼ $2.18	$20.04M	1.3	11.60 million shs	10.45 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	+1.79%	+15.89%	+30.34%	+25.14%	+46.14%
DGX Quest Diagnostics	-1.56%	-1.20%	+1.29%	+3.59%	+29.22%
HIMS Hims & Hers Health	-0.88%	+14.61%	-16.25%	+69.56%	+123.82%
LFMD LifeMD	-1.52%	+0.70%	+0.62%	+143.05%	+95.32%
LH Labcorp	-1.57%	+0.42%	+4.96%	+11.47%	+28.26%
LLY Eli Lilly and Company	+0.31%	-1.70%	+4.33%	-1.23%	-14.09%
MED Medifast	-0.20%	+11.60%	+9.92%	+11.99%	-28.68%
NVO Novo Nordisk A/S	-0.06%	+3.62%	-4.08%	+4.07%	-51.18%
TDOC Teladoc Health	-2.45%	+10.16%	+21.31%	+10.52%	-11.12%
WW WW International	0.00%	0.00%	0.00%	-53.86%	-77.81%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMWL American Well	3.4932 of 5 stars	3.1	4.0	0.0	0.0	3.2	2.5	1.3
DGX Quest Diagnostics	4.9379 of 5 stars	2.3	4.0	4.2	4.7	2.9	2.5	2.5
HIMS Hims & Hers Health	2.2014 of 5 stars	2.0	2.0	0.0	0.0	1.8	3.3	1.9
LFMD LifeMD	1.0678 of 5 stars	1.5	2.0	0.0	0.0	2.9	1.7	0.6
LH Labcorp	4.3884 of 5 stars	2.4	2.0	2.5	4.2	2.9	2.5	1.3
LLY Eli Lilly and Company	4.9887 of 5 stars	4.4	4.0	3.3	4.0	2.9	1.7	1.9
MED Medifast	3.9928 of 5 stars	2.0	1.0	0.0	2.0	3.8	3.3	2.5
NVO Novo Nordisk A/S	4.7497 of 5 stars	4.1	5.0	2.5	0.0	2.8	0.0	3.1
TDOC Teladoc Health	3.2195 of 5 stars	3.2	4.0	0.0	0.0	1.7	2.5	1.3
WW WW International	1.4746 of 5 stars	3.0	0.0	0.0	0.0	2.1	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.14	Hold	$9.67	13.59% Upside
DGX Quest Diagnostics	2.69	Moderate Buy	$185.73	3.85% Upside
HIMS Hims & Hers Health	1.92	Reduce	$39.58	-17.39% Downside
LFMD LifeMD	3.00	Buy	$12.00	-4.34% Downside
LH Labcorp	2.79	Moderate Buy	$276.08	5.42% Upside
LLY Eli Lilly and Company	2.75	Moderate Buy	$1,011.61	29.76% Upside
MED Medifast	2.00	Hold	$16.50	13.17% Upside
NVO Novo Nordisk A/S	2.27	Hold	$112.00	62.20% Upside
TDOC Teladoc Health	2.37	Hold	$9.60	16.54% Upside
WW WW International	2.00	Hold	$2.25	801.44% Upside

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/25/2025	LH Labcorp	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Cautious ➝ Cautious
6/25/2025	LH Labcorp	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$250.00 ➝ $275.00
6/24/2025	HIMS Hims & Hers Health	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$45.00
6/23/2025	HIMS Hims & Hers Health	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell
6/23/2025	HIMS Hims & Hers Health	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$30.00
6/23/2025	HIMS Hims & Hers Health	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform
6/23/2025	HIMS Hims & Hers Health	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
6/20/2025	LLY Eli Lilly and Company	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$936.00
6/18/2025	LFMD LifeMD	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$15.00 ➝ $18.00
6/11/2025	HIMS Hims & Hers Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Equal Weight ➝ Equal Weight	$40.00
6/11/2025	LH Labcorp	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$270.00 ➝ $283.00

(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$254.36M	0.52	N/A	N/A	$20.31 per share	0.42
DGX Quest Diagnostics	$9.87B	2.02	$13.67 per share	13.08	$61.38 per share	2.91
HIMS Hims & Hers Health	$1.48B	7.26	$0.36 per share	134.77	$2.16 per share	22.18
LFMD LifeMD	$212.45M	2.68	N/A	N/A	($0.09) per share	-139.39
LH Labcorp	$13.01B	1.69	$22.58 per share	11.60	$96.27 per share	2.72
LLY Eli Lilly and Company	$45.04B	16.40	$14.24 per share	54.75	$15.03 per share	51.87
MED Medifast	$602.46M	0.27	$2.93 per share	4.98	$19.21 per share	0.76
NVO Novo Nordisk A/S	$42.12B	7.32	$3.86 per share	17.90	$4.66 per share	14.82
TDOC Teladoc Health	$2.57B	0.56	$5.49 per share	1.50	$8.66 per share	0.95
WW WW International	$765.94M	0.03	$0.21 per share	1.18	($9.62) per share	-0.03

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$208.14M	-$10.19	N/A	N/A	N/A	-59.13%	-48.36%	-35.36%	7/30/2025 (Estimated)
DGX Quest Diagnostics	$871M	$7.91	22.61	17.05	2.47	8.81%	15.11%	6.65%	7/22/2025 (Estimated)
HIMS Hims & Hers Health	$126.04M	$0.69	69.44	92.14	1.74	9.24%	22.75%	15.51%	8/4/2025 (Estimated)
LFMD LifeMD	-$18.88M	-$0.34	N/A	104.54	N/A	-4.58%	N/A	-15.19%	8/6/2025 (Estimated)
LH Labcorp	$746M	$8.65	30.28	14.93	1.65	5.55%	15.27%	6.97%	7/24/2025 (Estimated)
LLY Eli Lilly and Company	$10.59B	$12.29	63.43	25.05	1.14	22.67%	85.51%	15.74%	8/7/2025 (Estimated)
MED Medifast	$2.09M	-$0.65	N/A	9.53	N/A	-1.29%	6.63%	4.81%	8/4/2025 (Estimated)
NVO Novo Nordisk A/S	$14.64B	$3.38	20.43	14.82	1.36	34.52%	80.94%	24.23%	8/6/2025 (Estimated)
TDOC Teladoc Health	-$1.00B	-$5.92	N/A	N/A	N/A	-39.66%	-11.01%	-4.66%	7/30/2025 (Estimated)
WW WW International	-$112.25M	-$0.89	N/A	N/A	N/A	-56.84%	N/A	-0.32%	7/30/2025 (Estimated)

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	AMWL American Well	-$1.90	N/A	N/A	N/A	$63.87 million	N/A
7/30/2025	Q2 2025	TDOC Teladoc Health	-$0.24	N/A	N/A	N/A	$621.91 million	N/A
7/24/2025	Q2 2025	LH Labcorp	$4.12	N/A	N/A	N/A	$3.49 billion	N/A
7/22/2025	Q2 2025	DGX Quest Diagnostics	$2.56	N/A	N/A	N/A	$2.73 billion	N/A
5/7/2025	Q1 2025	NVO Novo Nordisk A/S	$0.92	$0.92	N/A	$0.92	N/A	$11.87 billion
5/6/2025	Q1 2025	LFMD LifeMD	-$0.04	$0.01	+$0.05	$0.01	$62.47 million	$65.70 million
5/6/2025	Q1 2025	WW WW International	-$0.26	-$0.47	-$0.21	-$0.91	$178.53 million	$186.57 million
5/5/2025	Q1 2025	HIMS Hims & Hers Health	$0.12	$0.20	+$0.08	$0.20	$535.21 million	$586.01 million
5/1/2025	Q1 2025	AMWL American Well	-$3.09	-$1.73	+$1.36	-$1.19	$60.15 million	$66.83 million
5/1/2025	Q1 2025	LLY Eli Lilly and Company	$4.64	$3.34	-$1.30	$3.06	$12.77 billion	$12.73 billion
4/29/2025	Q1 2025	LH Labcorp	$3.73	$3.84	+$0.11	$2.52	$3.41 billion	$3.35 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
DGX Quest Diagnostics	$3.20	1.79%	N/A	40.46%	14 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LFMD LifeMD	N/A	N/A	N/A	N/A	N/A
LH Labcorp	$2.88	1.10%	N/A	33.29%	N/A
LLY Eli Lilly and Company	$6.00	0.77%	N/A	48.82%	11 Years
MED Medifast	N/A	N/A	N/A	N/A	N/A
NVO Novo Nordisk A/S	$1.64	2.38%	N/A	48.52%	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A
WW WW International	N/A	N/A	N/A	N/A	N/A

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/23/2025	LLY Eli Lilly and Company	quarterly	$1.50	0.78%	8/15/2025	8/15/2025	9/10/2025
5/14/2025	DGX Quest Diagnostics	quarterly	$0.80	1.86%	7/7/2025	7/7/2025	7/21/2025
4/10/2025	LH Labcorp	quarterly	$0.72	1.25%		5/29/2025	6/11/2025
5/5/2025	LLY Eli Lilly and Company	quarterly	$1.50	0.73%	5/16/2025	5/16/2025	6/10/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.92	2.89
DGX Quest Diagnostics	0.84	1.44	1.31
HIMS Hims & Hers Health	N/A	1.59	1.32
LFMD LifeMD	N/A	0.82	0.77
LH Labcorp	0.68	1.84	1.60
LLY Eli Lilly and Company	2.18	1.37	1.06
MED Medifast	N/A	3.52	2.87
NVO Novo Nordisk A/S	0.70	0.74	0.56
TDOC Teladoc Health	0.70	1.68	1.64
WW WW International	N/A	0.53	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
DGX Quest Diagnostics	88.06%
HIMS Hims & Hers Health	63.52%
LFMD LifeMD	35.52%
LH Labcorp	95.94%
LLY Eli Lilly and Company	82.53%
MED Medifast	95.51%
NVO Novo Nordisk A/S	11.54%
TDOC Teladoc Health	76.82%
WW WW International	86.18%

Insider Ownership

Company	Insider Ownership
AMWL American Well	11.82%
DGX Quest Diagnostics	8.16%
HIMS Hims & Hers Health	13.71%
LFMD LifeMD	18.40%
LH Labcorp	0.84%
LLY Eli Lilly and Company	0.13%
MED Medifast	2.90%
NVO Novo Nordisk A/S	0.07%
TDOC Teladoc Health	0.58%
WW WW International	8.12%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	1,040	15.61 million	13.77 million	Optionable
DGX Quest Diagnostics	56,000	111.64 million	102.53 million	Optionable
HIMS Hims & Hers Health	1,637	223.83 million	193.15 million	Optionable
LFMD LifeMD	230	45.45 million	37.09 million	Optionable
LH Labcorp	70,000	83.70 million	83.00 million	Optionable
LLY Eli Lilly and Company	47,000	947.74 million	946.50 million	Optionable
MED Medifast	870	10.99 million	10.67 million	Optionable
NVO Novo Nordisk A/S	77,349	4.47 billion	4.46 billion	Optionable
TDOC Teladoc Health	5,500	175.43 million	174.42 million	Optionable
WW WW International	7,700	80.28 million	73.38 million	Optionable

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Headlines

Recent News About These Companies

‘F1’ U.S. Opening Higher, Speeds Up To $57M; Jerry Bruckheimer Visits Cinemas: “Audiences Are Riveted, You Don’t See A Head Move”

July 2 at 11:22 AM | msn.com

WeightWatchers and Novo Nordisk Expand Collaboration to Improve Medication Access Through Trusted, Holistic Model of Care

July 2 at 11:22 AM | uk.finance.yahoo.com

Wegovy for $299? Retail Buzz Erupts As WeightWatchers, Novo Nordisk Expand Obesity Drug Push

July 2 at 11:22 AM | msn.com

WGHTQ - WW International Inc Chart - Morningstar

June 25, 2025 | morningstar.comM

WeightWatchers’ Reorganization Plan Confirmed, Clears Path for Elimination of Majority of Legacy Debt

June 19, 2025 | abladvisor.comA

WeightWatchers to exit process to cut $1.15 billion debt next week

June 17, 2025 | reuters.com

‘Lilo & Stitch' Nears $800M Global, ‘Mission: Impossible – Final Reckoning' Tops $450M & ‘Ballerina' Bows To $51M WW – International Box Office

June 8, 2025 | msn.com

ww international files for chapter 11, common stock delisted from nasdaq

June 4, 2025 | uk.investing.com

WW International Modifies Restructuring Agreement Amid Bankruptcy

June 2, 2025 | tipranks.com

WW International Stock Price History

May 31, 2025 | investing.com

Galloway Capital Partners Considering Legal Action Against Management and Board of Weight Watchers International, Inc.

May 22, 2025 | finance.yahoo.com

CheqUp and WeightWatchers Partner to Enhance GLP-1 Weight Loss Solutions in the UK

May 22, 2025 | quiverquant.comQ

CheqUp and WeightWatchers Announce Strategic Partnership to Support Growing Use of GLP-1 Medications in the UK

May 22, 2025 | globenewswire.com

Can Weight Watchers be saved? A look at the company as it files for bankruptcy

May 17, 2025 | msn.com

Watching the Watchers, Celebrity Status, and Harvester of Sorrow

May 13, 2025 | jdsupra.com

WW International: Equity Holders Face Near-Total Wipeout

May 12, 2025 | seekingalpha.com

Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs

May 10, 2025 | reuters.com

WeightWatchers Files For Bankruptcy, Hopes To Adapt In Weight-Loss Drug Era

May 9, 2025 | msn.com

WeightWatchers, which has 14 Long Island studios, filing for bankruptcy

May 9, 2025 | newsday.comN

WW Stock Plunges as WeightWatchers Files for Bankruptcy

May 9, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
By Jeffrey Neal Johnson | June 18, 2025
View 3 Catalysts in 7 Days: Archer's Growth Story Just Accelerated
AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!
By Thomas Hughes | June 16, 2025
View AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap!
Best Dollar Store Stock to Buy: Dollar Tree or Dollar General?
By Thomas Hughes | June 5, 2025
View Best Dollar Store Stock to Buy: Dollar Tree or Dollar General?
3 Notable Stocks Just Split: Which One Could Be the Big Winner?
By Leo Miller | June 26, 2025
View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Company Descriptions

American Well NYSE:AMWL

$8.51 -0.08 (-0.93%)

Closing price 03:30 PM Eastern

Extended Trading

$8.80 +0.29 (+3.41%)

As of 04:09 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Quest Diagnostics NYSE:DGX

$178.85 +2.25 (+1.27%)

Closing price 03:56 PM Eastern

Extended Trading

$177.79 -1.06 (-0.59%)

As of 04:46 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Hims & Hers Health NYSE:HIMS

$47.92 +0.46 (+0.96%)

Closing price 03:58 PM Eastern

Extended Trading

$47.82 -0.09 (-0.20%)

As of 05:00 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

LifeMD NASDAQ:LFMD

$12.54 -0.39 (-2.98%)

Closing price 03:53 PM Eastern

Extended Trading

$12.44 -0.10 (-0.80%)

As of 04:59 PM Eastern

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Labcorp NYSE:LH

$261.89 +1.89 (+0.73%)

Closing price 03:30 PM Eastern

Extended Trading

$261.87 -0.02 (-0.01%)

As of 04:20 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Eli Lilly and Company NYSE:LLY

$779.60 +0.32 (+0.04%)

Closing price 03:58 PM Eastern

Extended Trading

$778.00 -1.60 (-0.20%)

As of 04:58 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Medifast NYSE:MED

$14.58 -0.04 (-0.27%)

Closing price 03:30 PM Eastern

Extended Trading

$14.60 +0.03 (+0.17%)

As of 04:58 PM Eastern

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Novo Nordisk A/S NYSE:NVO

$69.05 -0.77 (-1.10%)

Closing price 03:58 PM Eastern

Extended Trading

$69.12 +0.08 (+0.11%)

As of 04:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teladoc Health NYSE:TDOC

$8.24 -0.12 (-1.38%)

Closing price 03:52 PM Eastern

Extended Trading

$8.24 0.00 (0.00%)

As of 04:58 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

WW International NASDAQ:WW

$0.25 -0.03 (-10.51%)

As of 05/15/2025

WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Earnings

Compare Dividends

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools